The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesFACS: Use 10µl for 106 cells.
IHC-P: Use at an assay dependent dilution.
IHC-Fr: Use at an assay dependent dilution.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
RelevanceThe CD45 family of cell surface glycoprotein antigens exist as a set of isoforms. The patterns of monoclonal antibody recognition of the CD45 phenotypes can be restricted (CD45RA, RB and RC), or broader, such as the CD45 T 200 species. The "restricted" subsets of this group arise as a result of translation of alternatively spliced mRNAs from exons A, B and C (exons 4, 5 and 6), where exons 3-15 encode the extracellular domain of the CD45 molecule. The restricted epitopes are differentially expressed on T and B lymphocytes, including functionally distinct T cells. CD45 (LCA) is a transmembrane phosphotyrosine phosphatase expressed on leucocytes. Myeloid cells do not express the RC isoform.
Cellular localizationMembrane; Single-pass type I membrane protein. Membrane raft. Note: Colocalized with DPP4 in membrane rafts.
EC 184.108.40.206 antibody
Leukocyte common antigen antibody
Ly5, homolog of antibody
Lymphocyte antigen 5 antibody
Protein tyrosine phosphatase receptor type C antibody
Receptor-type tyrosine-protein phosphatase C antibody
T200 Glycoprotein antibody
References for Anti-CD45RC antibody [MIL15] (ab14125)
has not yet been referenced specifically in any publications.
Publishing research using ab14125? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"